Layton H. Smith, Ph.D. - Publications

Affiliations: 
2002 Vanderbilt University, Nashville, TN 
Area:
Pharmacology

10 high-probability publications. We are testing a new system for linking publications to authors. You can help! If you notice any inaccuracies, please sign in and mark papers as correct or incorrect matches. If you identify any major omissions or other inaccuracies in the publication list, please let us know.

Year Citation  Score
2017 Rai R, Ghosh AK, Eren M, Mackie AR, Levine DC, Kim SY, Cedernaes J, Ramirez V, Procissi D, Smith LH, Woodruff TK, Bass J, Vaughan DE. Downregulation of the Apelinergic Axis Accelerates Aging, whereas Its Systemic Restoration Improves the Mammalian Healthspan. Cell Reports. 21: 1471-1480. PMID 29117554 DOI: 10.1016/J.Celrep.2017.10.057  0.448
2013 Boe AE, Eren M, Murphy SB, Kamide CE, Ichimura A, Terry D, McAnally D, Smith LH, Miyata T, Vaughan DE. Plasminogen activator inhibitor-1 antagonist TM5441 attenuates Nω-nitro-L-arginine methyl ester-induced hypertension and vascular senescence. Circulation. 128: 2318-24. PMID 24092817 DOI: 10.1161/Circulationaha.113.003192  0.46
2011 Siddiquee K, Hampton J, Khan S, Zadory D, Gleaves L, Vaughan DE, Smith LH. Apelin protects against angiotensin II-induced cardiovascular fibrosis and decreases plasminogen activator inhibitor type-1 production. Journal of Hypertension. 29: 724-31. PMID 21358420 DOI: 10.1097/Hjh.0B013E32834347De  0.444
2006 Smith LH, Dixon JD, Stringham JR, Eren M, Elokdah H, Crandall DL, Washington K, Vaughan DE. Pivotal role of PAI-1 in a murine model of hepatic vein thrombosis. Blood. 107: 132-4. PMID 16160004 DOI: 10.1182/Blood-2005-07-2681  0.492
2005 De Taeye B, Smith LH, Vaughan DE. Plasminogen activator inhibitor-1: a common denominator in obesity, diabetes and cardiovascular disease. Current Opinion in Pharmacology. 5: 149-54. PMID 15780823 DOI: 10.1016/J.Coph.2005.01.007  0.433
2005 Smith LH, Petrie MS, Morrow JD, Oates JA, Vaughan DE. The sterol response element binding protein regulates cyclooxygenase-2 gene expression in endothelial cells. Journal of Lipid Research. 46: 862-71. PMID 15716578 DOI: 10.1194/Jlr.M500021-Jlr200  0.56
2005 Shaklee JF, Talbot TR, Muldowney JA, Vaughan DE, Butler J, House F, Crowe JE, Smith LH, Edwards KM. Smallpox vaccination does not elevate systemic levels of prothrombotic proteins associated with ischemic cardiac events. The Journal of Infectious Diseases. 191: 724-30. PMID 15688286 DOI: 10.1086/427831  0.404
2004 Smith LH, Coats SR, Qin H, Petrie MS, Covington JW, Su M, Eren M, Vaughan DE. Differential and opposing regulation of PAI-1 promoter activity by estrogen receptor alpha and estrogen receptor beta in endothelial cells. Circulation Research. 95: 269-75. PMID 15217907 DOI: 10.1161/01.Res.0000136521.70093.F1  0.557
2003 Schoenhard JA, Smith LH, Painter CA, Eren M, Johnson CH, Vaughan DE. Regulation of the PAI-1 promoter by circadian clock components: differential activation by BMAL1 and BMAL2. Journal of Molecular and Cellular Cardiology. 35: 473-81. PMID 12738229 DOI: 10.1016/S0022-2828(03)00051-8  0.559
2002 Smith LH, Boutaud O, Breyer M, Morrow JD, Oates JA, Vaughan DE. Cyclooxygenase-2-dependent prostacyclin formation is regulated by low density lipoprotein cholesterol in vitro. Arteriosclerosis, Thrombosis, and Vascular Biology. 22: 983-8. PMID 12067908 DOI: 10.1161/01.Atv.0000019734.89917.35  0.538
Show low-probability matches.